Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02456233 · ClinicalTrials.gov registry record · NA

Evaluation of Conventional Ablation With or Without Focal Impulse and Rotor Modulation to Eliminate Human AF

A NA study of Atrial Fibrillation, sponsored by Stanford University.

Completed
Registry status
NA
Development phase
84
Enrollment target
2
Study locations

NCT02456233 is a NA study of Atrial Fibrillation that has completed, run by Stanford University. The registered enrollment target is 84 participants, below the 2,996-participant average among 202 other Atrial Fibrillation trials with a reported enrollment target (97% lower). The trial reports 2 study locations across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02456233, a NA study of Atrial Fibrillation, has completed, sponsored by Stanford University.

COMPLETED
Registry status
NA
Development phase
84 participants
Enrollment target
2
Study locations

Study Summary

This prospective randomized study will assess the safety and efficacy of FIRM-guided ablation (FIRM+PVI) compared to pulmonary vein isolation (PVI) without FIRM, for the treatment of symptomatic atrial fibrillation.

Conditions Studied

Interventions

  • PROCEDURE Conventional AF Ablation with PVI
  • PROCEDURE FIRM-guided ablation plus PVI

Study Locations (2)

California

  • Veterans Affairs Medical Center - San Diego
  • Stanford University - Stanford

Trial Details

FieldValue
Enrollment Target 84 participants
Start Date 2016-04
Est. Completion 2025-02
Phase NA

Sponsor

Stanford University

1,744 total trials

What the Registry Record Tells You About NCT02456233

The ClinicalTrials.gov registry entry for NCT02456233 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 84 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 2,996-participant average among 202 other Atrial Fibrillation trials with a reported enrollment target (97% lower). The listed sponsor is Stanford University, which has 1,744 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Atrial Fibrillation appearing as the primary indexed condition, and to 2 interventions - of which Conventional AF Ablation with PVI is the first listed.

NCT02456233 reports 2 study locations spanning 1 distinct geographic area - top geographies include California.

Frequently Asked Questions

What is clinical trial NCT02456233 about?

NCT02456233 is a clinical study titled "Evaluation of Conventional Ablation With or Without Focal Impulse and Rotor Modulation to Eliminate Human AF". This prospective randomized study will assess the safety and efficacy of FIRM-guided ablation (FIRM+PVI) compared to pulmonary vein isolation (PVI) without FIRM, for the treatment of symptomatic atrial fibrillation.

What is the current status of trial NCT02456233?

This trial is currently completed. It is a NA study. The enrollment target is 84 participants. The study started on 2016-04. Estimated completion is 2025-02.

What conditions does trial NCT02456233 study?

This clinical trial studies the following conditions: Atrial Fibrillation.

What interventions are being tested in trial NCT02456233?

The interventions under investigation include: Conventional AF Ablation with PVI (PROCEDURE), FIRM-guided ablation plus PVI (PROCEDURE).

Who is sponsoring clinical trial NCT02456233?

This trial is sponsored by Stanford University, which has 1,744 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT02456233 being conducted?

This trial has 2 study locations across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Atrial Fibrillation

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.